Definium Therapeutics (DFTX) Inventory (2019 - 2021)

Definium Therapeutics (DFTX) has 3 years of Inventory data on file, last reported at $6.7 million in Q2 2021.

• Quarterly Inventory rose 329.23% year-over-year to $6.7 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $6.7 million (up 329.23% YoY) and the FY2020 annual result came in at $3.0 million, down 3.8% from the prior year.
• Inventory improved to $6.7 million in Q2 2021 per DFTX's latest filing, from $6.1 million in the prior quarter.
• Across five years, Inventory topped out at $6.7 million in Q2 2021 and bottomed at $1.5 million in Q1 2020.
• The 3-year median for Inventory is $3.0 million (2020), against an average of $3.4 million.
• The widest annual swing landed in 2020, when Inventory dropped 3.8%; it then jumped 329.23% in 2021.
• Tracing DFTX's Inventory over 3 years: stood at $3.1 million in 2019, then dropped by 3.8% to $3.0 million in 2020, then surged by 123.17% to $6.7 million in 2021.
• Per Business Quant, the three latest DFTX Inventory figures stand at $6.7 million (Q2 2021), $6.1 million (Q1 2021), and $3.0 million (Q4 2020).

Peer Comparison